MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trial.
Saved in:
| Title: | MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trial. |
|---|---|
| Authors: | Ching TH; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.; Department of Psychological Sciences, University of Connecticut, Mansfield, CT, USA., Williams MT; School of Psychology, University of Ottawa, Ottawa, ON, Canada., Wang JB; MAPS Public Benefit Corporation, Santa Cruz, CA, USA., Jerome L; MAPS Public Benefit Corporation, Santa Cruz, CA, USA., Yazar-Klosinski B; Multidisciplinary Association for Psychedelic Studies, Santa Cruz, CA, USA., Emerson A; MAPS Public Benefit Corporation, Santa Cruz, CA, USA., Doblin R; Multidisciplinary Association for Psychedelic Studies, Santa Cruz, CA, USA. |
| Source: | Journal of psychopharmacology (Oxford, England) [J Psychopharmacol] 2022 Aug; Vol. 36 (8), pp. 974-986. Date of Electronic Publication: 2022 Jun 21. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Sage Publications Country of Publication: United States NLM ID: 8907828 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1461-7285 (Electronic) Linking ISSN: 02698811 NLM ISO Abbreviation: J Psychopharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
